CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 117 filers reported holding CUREVAC N V in Q3 2021. The put-call ratio across all filers is 2.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,960,115 | -23.5% | 490,898 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $3,868,276 | -49.1% | 490,898 | -12.0% | 0.00% | -50.0% |
| Q2 2022 | $7,592,583 | -23.5% | 557,868 | +10.2% | 0.00% | 0.0% |
| Q1 2022 | $9,925,837 | -38.8% | 506,162 | +7.0% | 0.00% | -33.3% |
| Q4 2021 | $16,227,000 | -19.4% | 472,962 | +28.4% | 0.00% | -25.0% |
| Q3 2021 | $20,122,000 | -16.4% | 368,406 | +12.5% | 0.00% | -20.0% |
| Q2 2021 | $24,061,000 | -46.4% | 327,444 | -33.3% | 0.01% | -50.0% |
| Q1 2021 | $44,869,000 | – | 490,788 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 3,134,780 | $286,707,000 | 46.92% |
| Ally Bridge Group (NY) LLC | 110,000 | $10,061,000 | 1.93% |
| Parametrica Management Ltd | 44,695 | $3,968,000 | 1.91% |
| Renaissance Capital LLC | 123,983 | $11,339,000 | 1.68% |
| Samsara BioCapital, LLC | 95,318 | $8,718,000 | 1.61% |
| Ikarian Capital, LLC | 360,000 | $32,925,000 | 1.11% |
| SECTOR GAMMA AS | 25,000 | $2,287,000 | 0.42% |
| Fosun International Ltd | 50,000 | $4,438,000 | 0.35% |
| Ikarian Capital, LLC | 100,000 | $9,145,000 | 0.31% |
| Baillie Gifford | 5,830,101 | $533,221,000 | 0.30% |